Perioperative Versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer- Prospect Lung

Sponsor:

Alliance for Clinical Trials in Oncology

Sponsor Study ID:

CTIU2317-A082304-S2402

CTO #:

104171

NCT Number:

NCT06632327

Phase:

III

Protocol Type:

Treatment

Age Group:

Adults

Disease Sites:

Lung

Study Objectives:

To compare the 3-year real-world event-free survival (rwEFS) rate and overall survival (OS) between perioperative and adjuvant immunotherapy-based treatment for patients with resectable non-small cell lung cancer (dual endpoints).

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)

---

Request more information